| abstract |
A novel crystalline 1,2-ethanedisulfonate salt of a biphenyl compound expected to be useful as a therapeutic factor for treating lung injury. The present invention relates to biphenyl-2-ylcarbamic acid 1- [2- (2-chloro-4-{[(R) -2-hydroxy-2- (8-hydroxy-2-oxo-1, A crystalline 1,2-ethanedisulfonate salt of 2-dihydroquinolin-5-yl) ethylamino] methyl} -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester, or a solvate thereof is provided. The invention also includes pharmaceutical compositions comprising such salts, or pharmaceutical compositions prepared using such salts; processes and intermediates for preparing such salts; and A method of treating pulmonary disorders using various salts is provided. [Selection] Figure 3 |